Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Short-term Investments (2016 - 2022)

Iradimed (IRMD) has disclosed Short-term Investments for 10 consecutive years, with $500090.0 as the latest value for Q1 2022.

  • Quarterly Short-term Investments fell 73.72% to $500090.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $500090.0 through Mar 2022, down 73.72% year-over-year, with the annual reading at $501855.0 for FY2021, 73.72% down from the prior year.
  • Short-term Investments for Q1 2022 was $500090.0 at Iradimed, roughly flat from $501855.0 in the prior quarter.
  • The five-year high for Short-term Investments was $8.2 million in Q2 2018, with the low at $500090.0 in Q1 2022.
  • Average Short-term Investments over 5 years is $3.6 million, with a median of $2.8 million recorded in 2019.
  • The sharpest move saw Short-term Investments rose 16.34% in 2018, then tumbled 73.72% in 2022.
  • Over 5 years, Short-term Investments stood at $6.3 million in 2018, then tumbled by 56.4% to $2.8 million in 2019, then tumbled by 31.03% to $1.9 million in 2020, then plummeted by 73.72% to $501855.0 in 2021, then decreased by 0.35% to $500090.0 in 2022.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $500090.0, $501855.0, and $945066.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.